13D/13G Filings - ImmunoPrecise Antibodies Ltd. (IPA)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-01-24
1:58 pm
Purchase
2024-12-31 13G ImmunoPrecise Antibodies Ltd.
IPA
Charmquark TWEE 1,828,365
5.800%
262,500increase
(+16.76%)
Filing
History
2024-02-27
10:33 am
Purchase
2024-02-13 13G ImmunoPrecise Antibodies Ltd.
IPA
INGALLS & SNYDER LLC 1,317,819
5.010%
264,633increase
(+25.13%)
Filing
History
2024-01-10
1:53 pm
Unchanged
2022-12-31 13G ImmunoPrecise Antibodies Ltd.
IPA
Charmquark TWEE 1,565,865
6.280%
0
(Unchanged)
Filing
History
2024-01-10
1:33 pm
Purchase
2022-04-13 13G ImmunoPrecise Antibodies Ltd.
IPA
Charmquark TWEE 1,565,865
6.400%
1,565,865increase
(New Position)
Filing
History
2023-07-07
3:22 pm
Purchase
2023-06-29 13D ImmunoPrecise Antibodies Ltd.
IPA
INGALLS & SNYDER LLC 1,053,186
4.220%
1,053,186increase
(New Position)
Filing
History